Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by The Heartland Institute referenced a study published in the December 2012 issue of The American Journal of Managed Care® (AJMC®) titled “Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization.” The study assessed the impact of the MDVIP personalized preventive care model on hospital utilization and found that MDVIP members’ utilization rates were substantially lower than those of nonmembers.
Posted on einnews.com, a press release cited an article published in an August 2017 supplement to AJMC®. The article, “Overview of Atopic Dermatitis,” noted that atopic dermatitis is a multifaceted, chronic relapsing inflammatory skin disease that is the most common skin disease in children, affecting approximately 15% to 20% of children and 1% to 3% of adults.
A piece by pharmiweb.com spotlighted an article published on AJMC.com, the website of AJMC®. The article, “ICER Report: Costs of Approved CAR T-Cell Therapies Aligned With Clinical Benefit,” noted that while the CAR-T cell therapies isagenlecleucel (Kymriah, Novartis) and axicabtagene ciloleucel (Yescarta, Kite Pharma/Gilead) may be high in price, a report by ICER finds that the cost-effectiveness of both therapies fell below or within commonly cited thresholds of $50,000 to $150,000 per quality-adjusted life-year.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More